Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Arteriosclerosis, Thrombosis, and Vascular Biology|July 21, 2012
Lipid effects of peroxisome proliferator-activated receptor-δ agonist GW501516 in subjects with low high-density lipoprotein cholesterol: characteristics of metabolic syndromeEric J Olson, Gregory L Pearce, Nigel P Jones, et al.
The Journal of Pediatrics|July 3, 2003
Sex hormones and the changes in adolescent male lipids: longitudinal studies in a biracial cohortJohn A Morrison, Bruce A Barton, Frank M Biro, et al.
Journal of Lipid Research|March 14, 2009
Mechanism of inhibition defines CETP activity: a mathematical model for CETP in vitroLaura K Potter, Dennis L Sprecher, Max C Walker, et al.
The American Journal of Medicine|December 31, 2002
Statins do not meet expectations for lowering low-density lipoprotein cholesterol levels when used in clinical practiceJoseph P Frolkis, Gregory L Pearce, Vijay Nambi, et al.
Atherosclerosis|December 4, 2003
Skin tissue cholesterol (SkinTc) is related to angiographically-defined cardiovascular diseaseDennis L Sprecher, Shaun G Goodman, Paul Kannampuzha, et al.
Circulation|October 8, 2003
Association between apolipoprotein E alleles and calcific valvular heart diseaseGian M Novaro, Ravish Sachar, Gregory L Pearce, et al.
Clinical Therapeutics|May 9, 2006
The association between fibrate use, change in high-density lipoprotein cholesterol, and the risk of cardiovascular disease: a retrospective chart review involving up to 8 years of follow-upGregory A Nichols, Carol E Koro, Wiley Chan, et al.
Pediatrics|July 5, 2006
Sensitivity and specificity of pediatric lipid determinations for adult lipid status: findings from the Princeton Lipid Research Clinics Prevalence Program Follow-up StudyLisa Aronson Friedman, John A Morrison, Stephen R Daniels, et al.
American Heart Journal|March 1, 2006
The independent correlation between high-density lipoprotein cholesterol and subsequent major adverse coronary eventsCarol E Koro, Steven J Bowlin, Timothy E Stump, et al.
Metabolism: Clinical and Experimental|March 26, 2002
Serum testosterone associates with lower high-density lipoprotein cholesterol in black and white males, 10 to 15 years of age, through lowered apolipoprotein AI and AII concentrationsJohn A Morrison, Dennis L Sprecher, Frank M Biro, et al.
Pageof 5